UC Davis — COVID-19 Antiviral Studies (Lark L. Coffey)

[Scientific Research] Grant Investigators: Heather Youngs and Chris Somerville This page was reviewed but not written by the grant investigators. UC Davis staff also reviewed this page prior to publication. Open Philanthropy recommended a grant of $100,642 to UC Davis to enable Associate Professor Lark L. Coffey to collaborate with researchers at Duke University and the Weill Cornell Medical College of Cornell University to study the effectiveness of an Hsp90 protein inhibitor as a host-directed antiviral against the COVID-19 virus. This follows our May 2020 support for earlier phases of the study at Duke University and falls within our work on scientific research, specifically within our interest in science supporting biosecurity and pandemic preparedness.